Dana Carroll

Biochemistry University of Utah, Salt Lake City, UT 
Biochemistry, Molecular Biology
"Dana Carroll"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yarrington RM, Verma S, Schwartz S, et al. (2018) Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo. Proceedings of the National Academy of Sciences of the United States of America
DeWitt MA, Magis W, Bray NL, et al. (2016) Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells. Science Translational Medicine. 8: 360ra134
Carroll D, Van Eenennaam AL, Taylor JF, et al. (2016) Regulate genome-edited products, not genome editing itself. Nature Biotechnology. 34: 477-479
Carroll D. (2016) A Perspective on the State of Genome Editing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 24: 412-3
Carroll D, Charo RA. (2015) The societal opportunities and challenges of genome editing. Genome Biology. 16: 242
Chandrasegaran S, Carroll D. (2015) Origins of Programmable Nucleases for Genome Engineering. Journal of Molecular Biology
Bosley KS, Botchan M, Bredenoord AL, et al. (2015) CRISPR germline engineering--the community speaks. Nature Biotechnology. 33: 478-86
Corrigan-Curay J, O'Reilly M, Kohn DB, et al. (2015) Genome editing technologies: defining a path to clinic. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 796-806
Hackett P, Carroll D. (2015) Regulatory hurdles for agriculture GMOs. Science (New York, N.Y.). 347: 1324
Baltimore D, Berg P, Botchan M, et al. (2015) Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science (New York, N.Y.). 348: 36-8
See more...